Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 421.67B | 421.67B | 370.68B | 417.62B | 462.82B | 302.38B |
Gross Profit | 14.70B | 14.70B | 13.67B | 16.14B | 14.33B | 7.86B |
EBITDA | 10.56B | 9.51B | 4.23B | 8.15B | 8.74B | 4.69B |
Net Income | 5.59B | 5.59B | 2.10B | 4.91B | 6.38B | 3.45B |
Balance Sheet | ||||||
Total Assets | 113.97B | 113.97B | 130.21B | 107.18B | 116.99B | 119.89B |
Cash, Cash Equivalents and Short-Term Investments | 5.80B | 5.80B | 20.86B | 12.14B | 8.22B | 9.55B |
Total Debt | 14.05B | 14.05B | 29.66B | 20.56B | 9.50B | 14.60B |
Total Liabilities | 64.35B | 64.35B | 84.70B | 62.98B | 77.63B | 87.09B |
Stockholders Equity | 49.62B | 49.62B | 45.51B | 43.21B | 38.59B | 32.17B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 9.20B | 4.15B | -5.25B | 5.74B | -11.61B |
Operating Cash Flow | 0.00 | 9.21B | 4.42B | -4.96B | 5.90B | -11.58B |
Investing Cash Flow | 0.00 | -21.00M | 494.00M | -263.00M | -183.00M | -30.00M |
Financing Cash Flow | 0.00 | -16.85B | 2.90B | 8.58B | -7.60B | 11.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | 47.27B | 9.61 | 13.29% | 3.13% | 7.19% | 45.73% | |
78 Outperform | 44.21B | 12.35 | 12.37% | 1.86% | 32.53% | 182.70% | |
76 Outperform | 27.17B | 10.76 | 7.81% | 4.54% | 5.49% | 17.69% | |
76 Outperform | 33.08B | 13.73 | 6.51% | 2.99% | 2.04% | -11.59% | |
75 Outperform | ¥45.64B | 8.58 | 4.58% | 9.23% | 13.49% | ||
58 Neutral | 46.76B | -263.83 | 0.35% | 4.33% | -61.35% | -104.58% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |